The Medical Marijuana Program
Pennsylvania recognizes 17 qualifying conditions for the state's medical marijuana program.
By Pennsylvania law, medical marijuana is limited to the following forms: pill; oil; topicals including gels, creams, ointments; tincture; liquid; or other forms deemed medically appropriate for vaporization or nebulization (excluding dry leaf).
The 17 qualifying conditions are:
- Amyotrophic Lateral Sclerosis
- Crohn’s Disease
- Damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity
- HIV (Human Immunodeficiency Virus) / AIDS (Acquired Immune Deficiency Syndrome)
- Huntington’s Disease
- Inflammatory Bowel Disease
- Intractable Seizures
- Multiple Sclerosis
- Parkinson’s Disease
- Post-traumatic Stress Disorder
- Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain in which conventional therapeutic intervention and opiate therapy is contraindicated or ineffective
- Sickle Cell Anemia
For more information, please see the Department of Health's website.
Illustrations courtesy of Pennsylvania Department of Health
The patient enrollment in Pennsylvania's medical marijuana program is explained above, for once the program is operational in 2018. For more information please see the Patients & Caregiver section on Department of Health website.
After we receive our permit we will conduct educational outreach events for qualifying patients who may benefit from medical marijuana. We will also begin identifying patients for our sickle cell anemia research with the Lambert Center for the Study of Medicinal Cannabis and Hemp at the Institute of Emerging Health Professions at Thomas Jefferson University.